TLSI · TriSalus Life Sciences, Inc.
$5.27
-0.36 (-6.39%)
At close · Aug 14
Going-concern doubt
— cleared Aug 6, 2026
The latest filing no longer states the doubt (first flagged May 12, 2026).
View the 10-Q filed Aug 6, 2026Market Cap
$324.50M
Shares
61.57M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2023-06-30 YTD | $8,479,333 | 10-Q, filed 2023-08-02 |
| 2022-12-31 | $232,371,273 | 10-K, filed 2023-03-22 |
Key facts
CIK
1826667
CUSIP
89680M101
13F (30d)
78 filings
78 filers
Visit website
Investor relations